Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo
evidenced by caspase and poly (ADP-ribose) polymerase cleavage
InChi: InChI=1S/C17H14Cl2F2N4OS/c1-8(2)16(26)23-17-22-7-13(27-17)12-6-11(15(20)21)24-25(12)14-9(18)4-3-5-10(14)19/h3-8
Chintala MS
4R)-1-((S)-2-(3-(2-((5-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)pentyl)oxy)ethoxy)propanamido)-3
SB939 ties MALT1 small molecule inhibitors specificallySB939, is an orally bioavailable, small molecule histone deacetylase (HDAC) inhibitor with potential antineoplastic activity. Pracinostat inhibits HDACs, which may result in the accumulation of highly acetylated histones, followed by the induction of chromatin remodeling; the selective transcription of tumor suppressor genes; the tumor suppressor protein mediated inhibition of tumor cell division; and, finally, the induction of tumor cell apoptosis.